Level Bio AB (XSAT:LEVBIO) FCF Margin % : -17.01% (As of Mar. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Level Bio AB's Free Cash Flow for the three months ended in Mar. 2024 was kr-0.94 Mil. Level Bio AB's Revenue for the three months ended in Mar. 2024 was kr5.50 Mil. Therefore, Level Bio AB's FCF Margin % for the quarter that ended in Mar. 2024 was -17.01%.

As of today, Level Bio AB's current FCF Yield % is -24.97%.

The historical rank and industry rank for Level Bio AB's FCF Margin % or its related term are showing as below:

XSAT:LEVBIO' s FCF Margin % Range Over the Past 10 Years
Min: -21.03 Med: 0.93 Max: 7.82
Current: -19.65

During the past 13 years, the highest FCF Margin % of Level Bio AB was 7.82%. The lowest was -21.03%. And the median was 0.93%.

XSAT:LEVBIO's FCF Margin % is ranked worse than
57.66% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -12.255 vs XSAT:LEVBIO: -19.65

Level Bio AB FCF Margin % Historical Data

The historical data trend for Level Bio AB's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB FCF Margin % Chart

Level Bio AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

0.40

7.82

3.70

7.51

-21.03

Level Bio AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-21.71	13.78	-39.05	-30.02	-17.01

Competitive Comparison of Level Bio AB's FCF Margin %

For the Diagnostics & Research subindustry, Level Bio AB's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Level Bio AB's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Level Bio AB's FCF Margin % falls into.

Level Bio AB FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Level Bio AB's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-5.489	/	26.096
	=	-21.03 %

Level Bio AB's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	-0.936	/	5.504
	=	-17.01 %

Level Bio AB FCF Margin % Related Terms

Thank you for viewing the detailed overview of Level Bio AB's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Level Bio AB (XSAT:LEVBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30

Website

http://www.alphahelix.com

AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines